232 related articles for article (PubMed ID: 1953317)
1. Upper extremity contractures in a patient with eosinophilia-myalgia syndrome.
Marchman HB; Gleason CB; Shaw JC
Arch Phys Med Rehabil; 1991 Nov; 72(12):1029-30. PubMed ID: 1953317
[TBL] [Abstract][Full Text] [Related]
2. [A case of the eosinophilia-myalgia syndrome].
Ishikawa A; Akahosi T; Okada J; Kondo H; Kasiwazaki S
Ryumachi; 1992 Aug; 32(4):327-30; discussion 330-2. PubMed ID: 1411794
[TBL] [Abstract][Full Text] [Related]
3. Demyelinating polyneuropathy in eosinophilia-myalgia syndrome.
Donofrio PD; Stanton C; Miller VS; Oestreich L; Lefkowitz DS; Walker FO; Ely EW
Muscle Nerve; 1992 Jul; 15(7):796-805. PubMed ID: 1323757
[TBL] [Abstract][Full Text] [Related]
4. Review of L-tryptophan and eosinophilia-myalgia syndrome.
Roufs JB
J Am Diet Assoc; 1992 Jul; 92(7):844-50. PubMed ID: 1624654
[TBL] [Abstract][Full Text] [Related]
5. Eosinophilia-myalgia syndrome in Wisconsin.
Butler JC; Davis JP
Wis Med J; 1990 Dec; 89(12):687-91. PubMed ID: 2293489
[TBL] [Abstract][Full Text] [Related]
6. The natural history of eosinophilia-myalgia syndrome in a tryptophan-exposed cohort in South Carolina.
Sullivan EA; Kamb ML; Jones JL; Meyer P; Philen RM; Falk H; Sinks T
Arch Intern Med; 1996 May; 156(9):973-9. PubMed ID: 8624177
[TBL] [Abstract][Full Text] [Related]
7. [Scleroderma and environment. III. Eosinophilia-myalgia syndrome and L-tryptophan].
Bournerias I; Castot A
Ann Dermatol Venereol; 1991; 118(12):962-8. PubMed ID: 1799247
[No Abstract] [Full Text] [Related]
8. Reduced severity of eosinophilia-myalgia syndrome associated with the consumption of vitamin-containing supplements before illness.
Hatch DL; Goldman LR
Arch Intern Med; 1993 Oct; 153(20):2368-73. PubMed ID: 8215741
[TBL] [Abstract][Full Text] [Related]
9. Bias or biology: evaluating the epidemiologic studies of L-tryptophan and the eosinophilia-myalgia syndrome.
Horwitz RI; Daniels SR
J Rheumatol Suppl; 1996 Oct; 46():60-72. PubMed ID: 8895182
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for developing eosinophilia myalgia syndrome among L-tryptophan users in New York.
Back EE; Henning KJ; Kallenbach LR; Brix KA; Gunn RA; Melius JM
J Rheumatol; 1993 Apr; 20(4):666-72. PubMed ID: 8496862
[TBL] [Abstract][Full Text] [Related]
11. Epidemiologic studies of the association of L-tryptophan with the eosinophilia-myalgia syndrome: a critique.
Shapiro S
J Rheumatol Suppl; 1996 Oct; 46():44-58; discussion 58-9. PubMed ID: 8895181
[TBL] [Abstract][Full Text] [Related]
12. Eosinophilia-myalgia syndrome associated with L-tryptophan. A case report with pulmonary manifestations and review of the literature.
André M; Canon JL; Levecque P; Dermine P; Mortier C; Leveau F
Acta Clin Belg; 1991; 46(3):178-82. PubMed ID: 1656679
[TBL] [Abstract][Full Text] [Related]
13. Fatal eosinophilia myalgia syndrome in a marrow transplant patient attributed to total parenteral nutrition with a solution containing tryptophan.
de Oliveira JS; Auerbach SB; Sullivan KM; Sale GE
Bone Marrow Transplant; 1993 Feb; 11(2):163-7. PubMed ID: 8435665
[TBL] [Abstract][Full Text] [Related]
14. [Eosinophilia-myalgia syndrome. Clinical aspects and follow-up of 10 patients].
Mensing H; Schallreuter KU; Senff H; Steinkraus V
Hautarzt; 1992 Jul; 43(7):436-40. PubMed ID: 1506202
[TBL] [Abstract][Full Text] [Related]
15. Eosinophilia-myalgia syndrome in association with L-tryptophan ingestion.
Gresh JP; Vasey FB; Espinoza LR; Adelman HM; Germain BF
J Rheumatol; 1990 Nov; 17(11):1557-8. PubMed ID: 2273503
[TBL] [Abstract][Full Text] [Related]
16. Clinical improvement of the myopathy in eosinophilia-myalgia syndrome with steroids and rehabilitative therapy.
Esper JJ; Nigro MA; Wishnow R; Barnett T; Perrotta AL; Richardson W
J Am Osteopath Assoc; 1992 Aug; 92(8):1056-8. PubMed ID: 1429067
[TBL] [Abstract][Full Text] [Related]
17. Structural characterization of contaminants found in commercial preparations of melatonin: similarities to case-related compounds from L-tryptophan associated with eosinophilia-myalgia syndrome.
Williamson BL; Tomlinson AJ; Mishra PK; Gleich GJ; Naylor S
Chem Res Toxicol; 1998 Mar; 11(3):234-40. PubMed ID: 9544622
[TBL] [Abstract][Full Text] [Related]
18. Eosinophilia-myalgia syndrome among the non-L-tryptophan users and pre-epidemic cases.
Sullivan EA; Staehling N; Philen RM
J Rheumatol; 1996 Oct; 23(10):1784-7. PubMed ID: 8895159
[TBL] [Abstract][Full Text] [Related]
19. L-tryptophan-induced eosinophilia-myalgia syndrome. I. Report of two cases with pseudoxanthoma-elasticum-like skin changes.
Mainetti C; Schmied E; Masouyé I; Chavaz P; Saurat JH
Dermatologica; 1991; 183(1):57-61. PubMed ID: 1769422
[TBL] [Abstract][Full Text] [Related]
20. Elevated L-kynurenine level and its normalization by prednisolone in a patient with eosinophilia-myalgia syndrome.
Hisatomi A; Kubota A; Ohashi M; Umeda F; Nawata H; Imamura T; Nagata T
Fukuoka Igaku Zasshi; 1997 Jan; 88(1):11-7. PubMed ID: 9037890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
